(Q34379808)

1 August 2017

1 reference

title

Infections in recipients of kidney transplants (English)

1 reference

1 August 2017

Patel R

1

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Infectious Disease Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

901-52, xi

1 reference

Peloisis hepatis due to Bartonella henselae in transplantation: a hemato-hepato-renal syndrome

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Emphysematous cystitis and pyelitis in a diabetic renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Infections and immunizations in organ transplant recipients: a preventive approach

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

High prevalence of hepatitis G virus (HGV) infection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Membranoproliferative glomerulonephritis with subendothelial deposits (type 1) associated with hepatitis G virus infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Congenital cytomegalovirus infection after recurrent infection in a mother with a renal transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Varicella and zoster in children after kidney transplantation: long-term results of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Immunization of pediatric solid organ transplant candidates and recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Bacillary angiomatosis in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

The impact of azathioprine on chronic viral hepatitis in renal transplantation: a long-term, single-center, prospective study on azathioprine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Disseminated histoplasmosis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Subclinical pneumonitis during cytomegalovirus infection after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cytomegalovirus-induced necrotizing and crescentic glomerulonephritis in a renal transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole administration and successful retransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Early infections in kidney, heart, and liver transplant recipients on cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Antimicrobial Chemotherapy for Legionnaires Disease: Time for a Change

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Phaeohyphomycotic soft tissue disease caused by Pleurophomopsis lignicola in a kidney transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Mycobacterium marinum infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Monitoring of CMV infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Impaired kidney transplant survival in patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Herpes simplex virus encephalitis in a renal transplant patient: diagnosis by polymerase chain reaction detection of HSV DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Primary Epstein-Barr Virus Infection in a Renal Transplant Recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Fatal case of Trichoderma harzianum infection in a renal transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

INTESTINAL MICROSPORIDIOSIS OCCURRING IN TWO RENAL TRANSPLANT RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETIL

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Autosomal dominant polycystic kidney disease in a kidney transplant population.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Fungal Infections in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Failure of ganciclovir prophylaxis to completely eradicate CMV disease in renal transplant recipients treated with intense anti-rejection immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Epstein-Barr virus-associated Hodgkin's disease following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cutaneous infection due to Cladophialophora bantiana in a patient receiving immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Influence of anti-rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Subcutaneous phaeohyphomycosis in a renal transplant recipient: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Laryngeal tuberculosis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Irreversible glomerular lesions induced by crystal precipitation in a renal transplant after foscarnet therapy for cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Fatal hepatitis B virus infection with fibrosing cholestatic hepatitis following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: effect of acute rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATION

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Mycobacterium tuberculosis infection of a native polycystic kidney following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

An outbreak of Legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cryptococcosis in a renal unit

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients: a matched-pair case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cystic smooth-muscle tumor of the liver and spleen associated with Epstein-Barr virus after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Strongyloides stercoralis in chronic renal failure: safe therapy with thiabendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Transmission ofHistoplasma capsulatumby Organ Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A Longitudinal Study of Varicella-Zoster Virus Infections in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Mycobacterial infection complicating renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Hepatitis C virus infections in transplant patients: serological and virological investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human parvovirus B19 infection in organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Nonfatal gastric mucormycosis in a renal transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Chronic anemia as a complication of parvovirus B19 infection in a pediatric kidney transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

An interesting case of failed renal transplant complicated by a lymphocele infected with Pasteurella multocida and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Progressive Multifocal Leukoencephalopathy in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Idiopathic thrombocytopenia after cytomegalovirus infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Phaeohyphomycosis in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A Case of Enterocytozoon bieneusi Infection in an HIV-Negative Renal Transplant Recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Routine perioperative antibiotic prophylaxis in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Bacteremia among kidney transplant recipients: a case-control study of risk factors and short-term outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Hepatitis C virus infection and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Glomerular diseases in patients with hepatitis C virus infection after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Opportunistic strongyloidiasis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Ureteritis and cholecystitis: two unusual manifestations of cytomegalovirus disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Transmission of Mycobacterium tuberculosis with renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cerebral tuberculoma 11 years after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Ischemic colitis secondary to venous thrombosis. A rare presentation of cytomegalovirus vasculitis following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Pyelonephritis and vesicoureteral reflux after renal transplantation in young children.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Streptococcus mitis: urinary tract infection in a renal transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Infections in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Continuous sulfa prophylaxis for urinary tract infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cytomegalovirus vaccine virus (Towne strain) does not induce latency

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

CMV infection is associated with transplant renal artery stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Legionella pneumonia in transplant recipients: a cluster of cases of eight years' duration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human polyoma virus-associated interstitial nephritis in the allograft kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Fatal disseminated Nocardia farcinica infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Antimicrobial strategies in the care of organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Epstein-Barr virus-associated post-transplant primary smooth muscle tumor of the liver: report of an autopsy case

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

The high incidence of tuberculosis among renal transplant recipients in India

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Multiple Cladosporium brain abscesses in a renal transplant patient: aggressive management improves outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Phaeohyphomycosis from Exphiala jeanselmei with concomitant Nocardia asteroides infection in a renal transplant recipient: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Tuberculosis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Blastomycosis in transplant recipients: report of a case and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human herpes virus 8 infection in kidney transplant patients in Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

A giant gastric ulcer caused by mucormycosis infection in a patient with renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Paracoccidioidomycosis in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Transmission of Human Immunodeficiency Virus Type 1 from a Seronegative Organ and Tissue Donor

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Successful treatment of infection due to Mycoplasma hominis with streptogramins in a renal transplant patient: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Posttransplant lymphoproliferative disorder in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Management of herpes virus infections following transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Posttransplant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Acute hemorrhagic cystitis by adenovirus type 11 with and without type 37 after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Relapsing Tinea capitis by Microsporum canis in an Adult Female Renal Transplant Recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Prevalence of Superficial Dermatomycoses in 73 Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Pretransplantation assessment of the risk of lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Strongyloides stercoralis infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Clostridium difficile colitis after kidney and kidney-pancreas transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Invasive pulmonary aspergillosis in the early postcardiac transplantation period

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Histoplasmosis in renal allograft recipients. Two large urban outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Hyperimmune globulin prophylaxis for cytomegalovirus infection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Cytomegalovirus-induced tubulointerstitial nephritis in a renal allograft treated by foscarnet therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Tuberculosis after renal transplantation: experience of one Turkish centre

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Coccidioidomycosis in renal dialysis and transplant patients: radiologic findings in 30 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Attenuated varicella virus vaccine in children with renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

Foscarnet-induced crystalline glomerulonephritis with nephrotic syndrome and acute renal failure after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970178-1

7 January 2021

10.1016/S0891-5520(05)70178-1

Identifiers

DOI

1 reference

1 August 2017

1 reference